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Abstract
Deﬁnitive identiﬁcation of promoters, their cis-regulatory motifs, and their trans-acting proteins
requires experimental analysis. To deﬁne the HNRNPK promoter and its cognate DNA–protein inter-
actions, we performed a comprehensive study combining experimental approaches, including luciferase
reporter gene assays, chromatin immunoprecipitations (ChIP), electrophoretic mobility shift assays
(EMSA), and mass spectrometry (MS). We discovered that out of the four potential HNRNPK promoters
tested, the one containing the palindromic motif TCTCGCGAGA exhibited the highest activity in a repor-
ter system assay. Although further EMSA and MS analyses, performed to uncover the identity of the palin-
drome-binding transcription factor, did identify a complex of DNA-binding proteins, neither method
unambiguously identiﬁed the pertinent direct trans-acting protein(s). ChIP revealed similar chromatin
states at the promoters with the palindromic motif and at housekeeping gene promoters. A ChIP survey
showed signiﬁcantly higher recruitment of PARP1, a protein identiﬁed by MS as ubiquitously attached
to DNA probes, within heterochromatin sites. Computational analyses indicated that this palindrome dis-
plays features that mark nucleosome boundaries, causing the surrounding DNA landscape to be constitu-
tively open. Our strategy of diverse approaches facilitated the direct characterization of various molecular
properties of HNRNPK promoter bearing the palindromic motif TCTCGCGAGA, despite the obstacles that
accompany in vitro methods.
Key words: HNRNPK promoter; palindromic motif; EMSA; mass spectrometry; chromatin
immunoprecipitation
1. Introduction
HNRNPK is an abundant protein factor found in the
nucleus, cytoplasm, mitochondria, and plasma mem-
brane that belongs to the family of heterogeneous
nuclear ribonucleoproteins (hnRNPs). These hnRNPs
are involved in a variety of biological processes,
including telomere biogenesis, cellular signalling,
DNA repair, and the regulation of expression on
both the transcriptional and translational levels.
1
HNRNPK has been found to activate and repress
gene expression, and its activity is mainly regulated
by covalent modiﬁcations.
2–4 Through its binding to
single-stranded (ss) and double-stranded (ds) DNA,
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Several studies have demonstrated the aberrant
increase in HNRNPK expression in cancers.
5–9 Other
studies have shown that HNRNPK is a functional con-
stituent of a cellular structure, the spreading initiation
centre,
10 and that it is indispensable for cellular
migration.
11 Overall, HNRNPK has been implicated
as a potential key player in carcinogenesis, making it
an attractive target for anticancer therapies.
Although HNRNPK has been the subject of numerous
studies, the mechanisms regulating its expression are
still largely unknown.
The palindromic motif TCTCGCGAGA has been
found in TATA-less promoters, and is a potential cis-
regulatory element in 5% of human genes including
cell cycle, transcription regulators, chromatin struc-
ture modulators, translation initiation factors, and
ribosomal protein genes.
12 Here, we present exper-
imental and computational evidence that the
TCTCGCGAGA motif represents a critical element in
the regulation of HNRNPK expression.
2. Materials and methods
2.1. Reporter plasmid construction
Sequences obtained from annotated databases
(GenBank and dbEST, available at the National
Center for Biotechnology Information; http://www.
ncbi.nlm.nih.gov) were analysed by bioinformatic
tools, leading to the identiﬁcation of four potential
HNRNPK promoters (Supplementary Table S1).
Promoter 1 contains the palindromic motif TCTCGC
GAGA.
All analysed HNRNPK promoter sequences were
ampliﬁed from human genomic DNA using Pfu
Turbo DNA polymerase (Agilent Technologies, Inc.,
Santa Clara, CA, USA) and primers, as listed in
Table 1; graphical location of analysed fragments is
shown in Fig. 1A. For promoter fragments 1, 2, and
3, nested polymerase chain reactions (PCRs) were
used, with pre-ampliﬁcation of long fragments with
the Promoter 1 forward and Promoter 3 reverse
primers pair. For Fragment 4, a standard PCR reaction
was used. The PCR-ampliﬁed DNA fragments were T/A
subcloned into the pCR 2.1-TOPO vector using the
TOPO TA Cloning kit (Invitrogen, Carlsbad, CA, USA),
and the resulting vectors were transformed into
chemically competent TOP10 cells. Plasmid DNA
was isolated from randomly selected bacterial clones
and sequenced using the ABI Prism 377 automated
DNA sequencing system (Applied Biosystems, Foster
City, CA, USA). Plasmids were digested with KpnI
and EcoRV (Promoters: 1, 2, 3) or with SacI and
EcoRV (Promoter 4), separated by agarose gel
electrophoresis, and DNA fragments isolated from
the gel were inserted into the corresponding restric-
tion sites of the pGL4.10[luc2] luciferase reporter
vector (Promega Corporation, Madison, WI, USA).
Site-directed mutagenesis was performed using the
QuikChange Multi Site-Directed Mutagenesis kit
(Agilent Technologies, Inc.) in the context of
pGL4.10[luc2]-promoter-1, according to the manu-
facturer’s protocol. All ﬁnal DNA constructs were con-
ﬁrmed by sequencing.
2.2. Transient transfection of HeLa cells
HeLa cells were grown at 378Ci n6 %C O 2 humidi-
ﬁed atmosphere in DME medium supplemented
with 10% foetal bovine serum (FBS), 2 mM glutamine,
100 units/ml penicillin, and 0.01% streptomycin in
plastic cell culture ﬂasks. Cells were routinely subcul-
tured using a trypsin solution. Prior to transfection,
cells were plated in ViewPlate-96 White plates
(PerkinElmer Wellesley, MA, USA) at 90% conﬂuency
and cultured overnight. Each well was transfected for
4 h using Lipofectamine 2000 Reagent (Invitrogen),
with 170 ng of the pGL4.10-promoter construct or
the empty pGL4.10 vector encoding the ﬁreﬂy lucifer-
ase gene, and co-transfected with 30 ng of the
phrl-CMV plasmid (Promega) encoding the Renilla
luciferase gene. To counterbalance minute differences
in construct length and to retain constant particle
numbers, the quantity of plasmid DNA was adjusted
relative to construct size. The quantity of phrl-CMV
plasmid DNA remained unchanged. Lipofectamine–
DNA complexes were prepared according to the man-
ufacturer’s instructions, except that MEM was used
instead of Opti-MEM medium. To maximize transfec-
tion efﬁciency during the 4 h incubation, the serum
complement was reduced to 0.5%. Afterward the
medium was changed to MEM containing 4% serum
and all standard complements. Twenty-four hours fol-
lowing transfection, cells were harvested and assayed
for luciferase activity in a Victor 2 luminometer
(PerkinElmer) using the Dual-Glow Luciferase Assay
System reagents (Promega) in accordance with the
manufacturer’s instructions. To normalize non-
speciﬁc variations in transfection efﬁciency and cell
number, all promoter activities were expressed as
the ratio of ﬁreﬂy luciferase to Renilla luciferase lumi-
nescence in each well. Three independent transfec-
tion experiments were conducted with six replicates
of each plasmid construct in each experiment. All
values are presented as mean+standard deviation.
2.3. Analyses of protein–DNA interactions
Non-histone nuclear protein extracts (NEs) were
isolated as previously reported.
13 Protein Desalting
Spin Columns (Pierce, Thermo Fisher Scientiﬁc,
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protein samples. Two methods were applied for ana-
lysing interactions between the palindromic motif
and DNA-binding proteins: electrophoretic mobility
shift assay (EMSA) and mass spectrometry (MS). The
sequences of oligonucleotides used in the study are
shown in Table 1.
2.3.1. Ku80 immunodepletion NEs were immu-
nodepleted of Ku80 protein using monoclonal anti-
Ku80 antibody (Abcam, Cambridge, UK; ab3107)
and Immunoprecipitation Kit—Dynabeads
w Protein G
(Invitrogen) according to the manufacturer’s protocol.
2.3.2. Electrophoretic mobility shift assay EMSA
were performed as described previously.
12 DNA
probes were phosphorylated with [g-
32P]ATP using
T4 polynucleotide kinase (Fermentas International
Inc., Burlington, Canada) according to the manufac-
turer’s protocol. The reaction was carried out in a
total volume of 15 ml (30 min at 258C) containing
2.5 mg of NE proteins and 1.4 pmol of oligonucleotide
in 100 mM NaCl-binding buffer (BB) (100 mM NaCl,
1 mM EDTA, 0.5 mM DTT, 10 mM Tris/HCl, pH 7.5).
EMSA was performed using 4 ml of the product on
an 8% non-denaturing polyacrylamide gel (37.5:1,
Promega) for 1 h at 7.5 V/cm. Autoradiograms were
Table 1. Oligonucleotide sequences used in this study
Primer pairs used for ampliﬁcation of promoter fragments
Promoter Forward primer 50–.30 Reverse primer 50–.30
Promoter 1 CTCCAACCCCAAAGGACTC* ATAATGGCGTCTGCAGTGCT
Promoter 2 GTTGGGGCTCCCTGAAAG CGGTCGGAGCTAGACAGAAA
Promoter 3 CCAGTTTTTCCGCTTGAGG CCACTGCCCGAGACAAAG*
Promoter 4 TTGGTGGTGTGGGAATTTTT TGGCATTGTACTGCATTGGT
Primer pairs used in ChIP
Gene name Forward primer 50–.30 Reverse primer 50–.30
Intergenic GCCACATTCAGTTCTCGCTTT TTCTCCTTTCCCTGGCAACA
RHO_intron2 TGGGTGGTGTCATCTGGTAA GGATGGAATGGATCAGATGG
RHO_exon5 GGACATCCACCAAGACCTACTG ATATGTTCTCCCTTCCCATTCA
HBB TTATGCTGGTCCTGTCCTCC CTGAAAGAGATGCGGTGG
HNRNPK TCGTTCGCGCACTCACTA CGCGTGAACTAGGCAGTTGT
TUBB6 AAGGGGCAGCGAAACGGTGG GGAGCCGGGCGGAAAAGGAC
GAPDH TGAGCAGTCCGGTGTCACTA AGGACTTTGGGAACGACTGA
HNRNPH ACAGCTGCGCAACCCACCAC CGCGAGACGGGAAAGTCGGT
RPS7 CCGCCTCTTGCCTTCGGACG CCGAGCGCCGGCTTAGGAAG
HSP70 GGCGAAACCCCTGGAATATTCCCGA AGCCTTGGGACAACGGGAG
EGR-1 GGTCCTGCCATATTAGGGCTT TGGGATCTCTCGCGACTCC
Primers used in mutagenesis
Primer name Primer sequence
P1M1 50-CAGTTGTTAGATCTCGTGAGAGGTTCGCCCCCTAG-30
P1M2 50-CAGTTGTTAGATCTCGTAAGAGGTTCGCCCCCTAG-30
P1M3 50-CAGTTGTTAGATCTCGTAGGAGGTTCGCCCCCTAG-30
Probes used in EMSA and MS
P1-30-F 50-AGTTGTTCTATCTCGCGAGAGGTTCGCCCC-30 (þ/2 biotin)
P1-30-R 50-GGGGCGAACCTCTCGCGAGATAGAACAACT-30
P1M-30-F 50-AGTTGTTCTATCTCGTAGGAGGTTCGCCCC-30
P1M-30-R 50-GGGGCGAACCTCCTACGAGATAGAACAACT-30
P1-16-F 50-CTATCTCGCGAGAGGT-30 (þ/2 biotin)
P1-16-R 50-ACCTCTCGCGAGATAG-30
P1M-16-F 50-CTATCTCGTAGGAGG-30
P1M-16-R 50-ACCTCCTACGAGATAG-30
*Primers used for pre-ampliﬁcation in nested PCR.
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Imager FX (BioRad, Hercules, CA, USA).
2.3.3. Ms Fifty micrograms of NE diluted in
50 mM NaCl-BB [50 mM NaCl, 1 mM EDTA, 0.05%
NP-40, 5 mM Tris–HCl, pH 7.5, containing protease
inhibitors (Roche, Basel, Switzerland)] were incub-
ated at 48C for 60 min with rotation, in the presence
of 200 pM biotinylated wild-type DNA probe with
or without a 10-fold excess of competitor (non-
biotinylated DNA probe containing the mutated
motif). To precipitate the DNA–protein complexes,
1 mg of Dynabeads
w M-280 Streptavidin (Invitrogen)
was added and the mixture was incubated with
rotation at 48C for 15 min. After magnetic separation,
the beads were extensively washed with 150 mM
NaCl-BB, and the bound proteins were eluted from
the beads with 300 mM NaCl, 500 mM NaHCO3,
1 mM EDTA, 5 mM Tris–HCl, pH 7.5. Eluted proteins
were subjected to reduction, alkylation, tryptic diges-
tion, and MS identiﬁcation.
2.3.4. LC-MS settings LC-MS analyses were
carried out using the nano-Acquity (Waters
Corporation, Milford, MA, USA) LC system coupled to
an LTQ FTICR (Thermo Fisher Scientiﬁc, Waltham, MA,
USA) mass spectrometer. Spectrometer parameters
were as follows: capillary voltage—2.5 kV, cone—40 V,
N2 gas ﬂow—0, and m/z range—300–2000. The spec-
trometer was calibrated on a weekly basis with Calmix
(Thermo Fisher Scientiﬁc). Samples were loaded from
the autosampler tray (cooled to 108C) to the precol-
umn [Symmetry C18, 180 mm  20 mm, 5 mm
(Waters)] using a mobile phase of 100% MilliQ water
acidiﬁed with 0.1% formic acid. Peptides were trans-
ferred to the nano-UPLC column [BEH130 C18,
75 mm  250 mm, 1.7 mm (Waters)] by a gradient of
5–30% ACN in 0.1% formic acid in 45 min (250 nl/
min), then directly eluted to the ion source of the
mass spectrometer. Each LC run was preceded by a
blank run to ensure lack of carry-over of the material
from the previous run. For qualitative analyses
(peptide and protein identiﬁcation), the spectrometer
was run in data-dependent MS to MS/MS switch mode,
and up to ten MS/MS processes were allowed for each
MS scan. Quantitative analyses were carried out in sep-
arate proﬁle type survey scan LC-MS runs using the
same ACN gradient.
Figure 1. Graphical localization of HNRNPK promoters and their activity in HeLa cells. (A) Information from the annotated sequence
databases GenBank and dbEST was analysed by computational tools, permitting the identiﬁcation of four potential HNRNPK
promoters. Localization of potential promoters sequences (vertical bars) are superimposed on three HNRNPK mRNA transcripts
derived from the UCSC browser (hg18 genome assembly) http://genome.ucsc.edu (chr9:85772500-85786000). (B) HeLa cells
were transiently transfected with constructs of four human HNRNPK promoters (P1, Promoter 1, containing the TCTCGCGAGA
motif; P2, Promoter 2; P3, Promoter 3; P4, Promoter 4) fused to a luciferase reporter gene (pGL4.10) and cotransfected with the
phrl-CMV plasmid encoding the Renilla luciferase gene as an internal control. (C) HeLa cells were transfected with mutated forms of
the HNRNPK promoter 1 (P1M1, single mutation; P1M2, double mutation; P1M3, triple mutation; pGL4.10, null plasmid). Luciferase
activities were measured 24 h after transfection. Mean ﬁreﬂy luciferase activities were normalized to Renilla luciferase activities
measured for different promoter reporter plasmids. Data are expressed as a percentage of promoter fragment 1 activity, and
represent the mean+standard deviation of three independent experiments.
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MS raw data ﬁles were processed to peak lists with the
Mascot Distiller software (version 2.2.1, Matrix
Science, London, UK). The pre-processed parent and
daughter ion lists were used to search the Swissprot
(http://www.expasy.org/sprot/) protein database, with
taxonomy restriction to human (20 332 sequences,
11 229 110 residues). The Mascot search engine
(version 2.2.03, Matrix Science, London, UK) was used
to search the database with the following parameters:
enzyme speciﬁcity—semi-trypsin, permitted number
ofmissedcleavages—1,ﬁxedmodiﬁcation—carbamido-
methylation(C),variable modiﬁcations—oxidation (M),
phospho (ST), phospho (Y), and carbamidomethyl (K),
protein mass—unrestricted. The peptide and fragment
mass tolerance settings were established separately for
individual experiments after measured mass recalibra-
tion (Supplementary Method 1).
Statistical assessment of peptide assignments was
basedonthe joinedtarget/decoydatabasesearchstrat-
egy. This procedure (Supplementary Method 2) pro-
vided q-value estimates for each peptide spectrum
match (PSM) in the dataset. All PSMs with q-values
.0.001 were removed from further analysis. A protein
was regarded as conﬁdently identiﬁed if at least two
peptides of this protein were found. Proteins identi-
ﬁed by a subset of peptides from another protein
were excluded from analysis. Proteins matching
exactly the same set of peptides were joined into a
single group.
2.3.6. Quantitative feature extraction The lists of
peptides matching the acceptance criteria from all
the LC-MS/MS runs were merged into one common
list, which was next overlaid onto 2-D heat maps gen-
erated from the LC-MS proﬁle data. This list was used
to tag the corresponding peptide-related ion spectra
on the basis of mass difference, deviation from the
predicted elution time, and the match between the
theoretical and observed isotopic envelopes. A more
detailed description of the quantitative feature extrac-
tion procedure implemented by our in-house soft-
ware is available.
14 The relative abundance of each
peptide was determined as the volume of a 2-D ﬁt
to the two most prominent peaks of the tagged isoto-
pic envelope.
Multiple-charge states of the same peptide were
combined by summing their relative abundances.
Missing abundance values (signals below the detec-
tion level of the instrument) were replaced by a refer-
ence value equal to the smallest abundance observed
in the entire LC-MS analysis. Normalization was
carried out on the log-transformed peptide abun-
dances by ﬁtting a robust locally weighted regression
smoother (LOESS) between the individual samples
and a median pseudo-sample.
2.3.7. Statistical analysis of quantitative MS
results Principal components analysis
(PCA) was used for graphical summarization and
evaluation of the relationships among the studied
samples. The statistical signiﬁcance of protein abun-
dance ratios was assessed by a one-sample t-test of
the log-transformed peptide ratios for each protein.
The resulting P-values were adjusted for multiple
hypothesis testing using the Benjamini–Hochberg
procedure that controls the false discovery rate
(FDR).
15 All statistical analyses were performed using
proprietary software implemented in the MATLAB
(MathWorks) environment.
2.4. Chromatin immunoprecipitation
Chromatin cross-linking and cell harvesting were
performed as previously described.
16 Chromatin was
sheared for seven rounds of 20 s (1 s pulse, 0.5 s
gap) on-off pulses with a 500-Watt Ultrasonic
Processor (Cole-Parmer Instrument Co., Vernon Hills,
IL, USA) equipped with a microtip and set to 30% of
maximum power. Chromatin immunoprecipitation
(ChIP) assays were performed using the Matrix-ChIP
platform as previously described.17 Brieﬂy, in-house
prepared polypropylene 96-well PCR plates (washed
once with 200 mlP B S /well) were incubated overnight
at room temperature with 0.2 mg of Protein A in
100 mlP B S /well. After washing with 200 mlP B S /
well, the wells were blocked with 200 ml blocking
buffer for 30 min at room temperature. The wells
were cleared, then incubated with 0.5 mg antibody
[anti-RNAPII-CTD (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), sc-47701; anti-Histone H3, Abcam,
ab1791; anti-Histone H3K4me3, Abcam, ab8580;
anti-Histone H3K27me3 (Millipore, Billerica, MA,
USA), 07-449; anti-Histone H3Ac(Lys9/18),
Millipore, 07-593; anti-PARP, Abcam, ab6079]
diluted in 100 ml blocking buffer/well for 60 min at
room temperature. Chromatin samples (4 ml chroma-
tin/100 ml blocking buffer) were added to the wells
(100 ml/well), and the plates were ﬂoated in a 48C
ultrasonic water bath for 1 h in order to accelerate
protein-antibody binding. Wells were washed three
times with 150 ml IP buffer and once with 150 mlT E
buffer. Wells were incubated with 100 ml elution
buffers in a thermocycler for 15 min at 568C, fol-
lowed by 15 min at 958C. DNA samples were stored
at 2208C in the original Matrix-ChIP plates for
repeated use.
The PCR mixture contained 2.5 ml2   SYBR Green
PCR master mix (SensiMix, Bioline, London, UK),
2.4 ml DNA template, and 0.1 ml primers (200 nM
each) in 5 ml ﬁnal volume. The reactions were run
in 384-Well Optical Reaction Plates (Applied
Biosystems). Ampliﬁcation (two step, 40 cycles), data
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7900HT Real-Time PCR system (Applied Biosystems).
All PCR reactions were performed in triplicate. ChIP
data are expressed as percent of input DNA as
described previously,
17 or as an input ratio of modi-
ﬁed histone to total histone H3. The RNAPII/H3Ac
ratio was calculated for each site tested by dividing
the averaged RNAPII percent of input and the H3Ac/
H3 level for all time points. The ChIP data are depos-
ited in Supplementary Table S5. The primer
sequences are listed in Table 1.
2.5. Electrophoresis and immunoblotting
Equal amounts of sample proteins (5 mg) were sep-
arated by 10% SDS–PAGE, electrotransfered to the
Polyvinylidene Diﬂuoride (PVDF) membrane and
immunostained by standard methods as previously
described.
18
2.6. Extraction of an open chromatin ENCODE data for
the promoters with the TCTCGCGAGA motif
The DNase-seq tracks at HNRNPK promoter
(chr9:85785291-85785515) for HepG2, HeLa,
k562, and GM12878 cell lines were obtained from
the ENCODE Open Chromatin, Duke DNase-seq Base
Overlap Signal datasets
19 using the UCSC browser
(hg18 genome assembly) http://genome.ucsc.edu.
For acquiring an averaged open chromatin proﬁle of
50 promoters bearing the palindromic motif the
CisRED (http://www.cisred.org) Human 9 database
was queried with TCTCGCGAGA sequence and the
resulting coordinates of 50 promoters were used to
extract the DNase-seq tracks for HeLa cell line (The
ENCODE Open Chromatin, Duke DNase-seq Base
Overlap Signal dataset). The open chromatin proﬁles
were superimposed over the TCTCGCGAGA sequence
present in each of the 50 promoters and extended
over a 150 bp window.
3. Results and discussion
3.1. TCTCGCGAGA is the primary regulatory element
of the HNRNPK promoter
Although computational approaches permit identi-
ﬁcation of gene regulatory and coding sequences,
deﬁnitive characterization of promoters and their
cis-regulatory motifs requires experimental investi-
gation.
20 To identify which bioinformatically ident-
iﬁed potential HNRNPK promoter(s) preferentially
activates transcription, a series of promoter region
fragments fused to a reporter gene were generated,
and these constructs were transiently transfected
into HeLa cells. Reporter plasmids contained four frag-
ments of an HNRNPK promoter region (Fig. 1A).
Sequences were identical to the human reference
sequence (GenBank, NC_000009.10), with the
exception of two single nucleotide polymorphisms:
rs7859578 in promoter fragment 1, and rs796 004
in promoter fragment 3. The highest luciferase
activity resulted from the reporter with HNRNPK pro-
moter fragment 1. Fragment 2 produced ,20% of the
luciferase activity obtained with reporter fragment 1,
while the luciferase activities generated by constructs
containing Fragments 3 and 4 were marginal
(Fig. 1B).
Thus, promoter region 1 can be assumed to be the
major HNRNPK promoter. It contains the palindromic
motif TCTCGCGAGA, which has been recently
grouped with the most-conserved motifs in a
genome-wide human–mouse assessment of six to
eight nucleotide segments.
12 Palindromic motifs con-
stitute an important group of regulatory elements. To
further study the signiﬁcance of this particular motif,
we designed a series of Promoter 1 reporter con-
structs with mutated sequences at one, two, and
three conserved nucleotide positions. Transcription
assays revealed marked luciferase activity decreases
in cells transfected with constructs containing the
mutant motifs. A single point mutation in the palin-
dromic motif resulted in a .80% loss of promoter
activity, whereas triple mutations reduced the activity
to near basal levels, demonstrating that this single
regulatory site is essential for the majority of
HNRNPK promoter activity (Fig. 1C). Similar results
were demonstrated by Guo et al.,
21 who investigated
the role of this motif in FBN1 gene activity; the activity
of a reporter gene decreased signiﬁcantly when two
middle nucleotides in the palindrome were replaced
with two non-canonical nucleotides.
3.2. In vitro searches for the palindromic motif’s
interacting protein(s)
Regulatory elements that are concentrated in pro-
moters (cis-elements) are recognized by trans-acting
proteins that control transcriptional efﬁciency. To
analyse the interactions between nuclear proteins
and the palindromic motif in vitro, we performed
EMSA and MS-based analyses.
In order to characterize pertinent binding inter-
actions, we used NEs, ds 16 and 30 bp DNA probes,
and ss 16 and 30 oligonucleotide (nt) probes con-
taining either the wild-type palindromic motif or a
similar motif mutated at three nucleotide positions
(Table 1). As shown in Fig. 2, a protein complex
bound to 16 bp (Fig. 2A) and 30 bp (Fig. 2B) ds
probes, containing either the wild-type or mutated
motif, caused a similar DNA mobility shift in the
form of a single band (Fig. 2, left panels). The wild-
type ss oligonucleotide probes, on the other hand,
formed two main protein–DNA complexes
250 Palindromic Motif Regulates the HNRNPK Promoter [Vol. 17,represented by the typically shifted band and a slowly
migrating band (Fig. 2, right panels). When the wild-
type 16 nt probe was replaced with a mutated oligo-
nucleotide, the binding activity of the protein complex
was substantially abolished (Fig. 2C). In contrast,
replacing the wild-type 30 nt sequence with a
mutated probe did not change the intensity of the
upper band, and signiﬁcantly increased the intensity
of the lower band (Fig. 2D).
With the exception of the ss 16 nt probes, the other
probes predominantly captured proteins in a
sequence-non-speciﬁc manner; most of the signal
originating from the shifted band was supershifted
by antibodies directed against ATP-dependent DNA
helicase 2 subunit 2 (Ku80), one of the proteins
forming DNA double-strand break repair com-
plexes.
22 Immunodepletion of Ku80 from the NEs
had no effect on the supershift pattern, although
the overall binding signal was weaker (Fig. 2). On
the other hand, the EMSA with a 16 nt ss probe pro-
duced quite a different picture of afﬁnity to nuclear
factors when compared with the activity of the
other DNA probes. The supershift signal introduced
by the anti-Ku80 antibody was much weaker in this
assay, and competitor binding was diminished. This
result suggests that the palindromic sequence in a
single-stranded conformation may represent a func-
tional cis-element. Since a palindromic motif may
form a hairpin structure only when single-stranded,
it is plausible that this state preferentially favours
certain nuclear factors, or facilitates changes in local
chromatin structure that drive transcription from pro-
moters bearing that sequence.
To gain a broader view of the protein repertoire that
might exist in complexes with the DNA probes, MS-
based analyses were applied. We used NEs isolated
from resting and proliferating cells in binding reac-
tions with four 50-biotinylated ss and ds probes, of
two lengths, containing the palindromic motif
sequence TCTCGCGAGA. Paired binding reactions
were performed with and without a 10-fold excess
of a competitor with similar characteristics (ss or ds,
shorter or longer, non-biotinylated probe with a
mutated motif). In addition, binding reactions were
repeated using NEs that were depleted by immuno-
precipitation with anti-Ku80 antibodies. Altogether,
quantitative MS analyses of proteins bound to the
DNA probes were carried out on 32 individual
samples.
Database searches were performed on 135 592
MS/MS spectra, resulting in the identiﬁcation of
15 150 PSMs with q-values   0.001 (corresponding
to 2268 unique peptides). In total, 522 proteins
were identiﬁed. Some proteins were represented by
multiple peptides in all analytical MS runs, whereas
other proteins appeared in individual runs as singular
peptides; 297 proteins were identiﬁed by at least two
peptides. Two proteins were detected by the MS/MS
analysis only in the depleted samples, while 33 pro-
teins were found only in the samples using crude
NEs. Two hundred and sixty-two proteins were
common to both experimental conditions. For statisti-
cal analysis we selected a subset of 132 proteins
identiﬁed by at least three peptides that were anno-
tated with the GO term nucleus (GO: 0005634),
after exclusion of ribosomal proteins and histones
(Supplementary Table S2).
Normalized relative protein abundances were ﬁrst
transformed to corresponding principal-component
scores. In the resulting plot (Fig. 3), the ﬁrst com-
ponent divided the analysed samples into two distinct
groups by discriminating between the binding of ss
and ds sequences, although the second component
discriminated based on probe length.
Proteins may interact with a DNA sequence directly
and/or indirectly, in both sequence-speciﬁc and -non-
speciﬁc manners. Assuming that a competitor com-
petes out non-speciﬁc DNA–protein interactions, we
constructed a protein abundance ratios matrix. The
elements of the matrix were equal to the ratios of
the protein abundances measured in the paired
binding reactions conducted with and without DNA
competitor molecules. We assumed that lack of stat-
istically signiﬁcant changes in the protein abundance,
or its enrichment within protein complexes existing in
Figure 2. Electrophoretic mobility shift assay of in vitro binding of
TCTCGCGAGA motif probes. Intact or Ku80-depleted NEs,
prepared from proliferating HeLa cells, were incubated with a
32P-labelled (A) ds 16 bp probe, (B) ds 30 bp probe, (C) ss 16
nt probe, or (D) ss 30 nt probe and resolved on the gel. WT,
wild-type probe, containing proper palindrome motif; MT,
mutated probe.
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teins are bound to DNA probes in a sequence-speciﬁc
manner.
As already demonstrated by PCA, the relative abun-
dances of DNA probe-associated proteins, and the
protein compositions of DNA–bound complexes,
were mostly dependent on probe sequence.
Although the relative levels of 75 proteins, extracted
from the nuclei of both resting and proliferating
cells and associated with ss 16 nt and 30 nt probes,
were not changed or were enriched in the binding
reactions conducted in the presence of a competitor,
the same was true only for 21 proteins associated
with ds DNA probes (Supplementary Table S3).
Further depletion of NEs by anti-Ku80 antibodies
treatment additionally reduced the numbers of pro-
teins which interaction with wild-type motif was unaf-
fected by competitors to 40 and 8, respectively
(Supplementary Table S4). Only three proteins
(P46 013, Antigen KI-67; Q09666, Neuroblast differ-
entiation-associated protein AHNAK; Q5SSJ5,
Heterochromatin protein 1-binding protein 3) were
common to all experimental settings.
Therefore, analysis by EMSA and MS of the in vitro
formation of DNA–protein complexes revealed com-
positional complexity of proteins interacting with
the DNA probes, but did not select trans-acting pro-
tein(s) that unambiguously directly recognize and
bind the palindromic motif TCTCGCGAGA.
EMSA is a well-established method of monitoring
the ability of a protein to bind to a DNA sequence
in vitro. Despite the fact that it has been successfully
employed to characterize transcription factors and
the transcriptional regulation of various genes,
23 it
also responds to non-speciﬁc protein binding, as in
the case of the abundant DNA repair proteins. In
particular, a heterodimer of Ku80 and Ku70 binds
with high afﬁnity to DNA ends, attracting the other
components of the DNA double-strand break repair
machinery.
22 We have encountered this inherent
technical ﬂaw during our EMSA of oligonucleotides
containing the palindromic motif. Recently, Hu
et al.
24 used a protein microarray-based strategy to
systematically characterize the repertoire of proteins
bound to 752 predicted DNA motifs from previously
published studies; the palindrome TCTCGCGAGA was
characterized among them. Using their data depos-
ited in the Human Protein-DNA Interactome data-
base,
25 we obtained a list of 21 proteins with
reported in vitro afﬁnity to this motif: LIG1, MTCP1,
HOXB9, TRIP6 PHOX2A, TFAP2E, RBPMS2, NEIL2,
MYOD1, ETV7, CREB5, RBM19, TCF7, C1orf25 LIG3,
ACTL6B, MAFB, ZNF498, SORCS3, POU6F1, IRF3, and
PARP3. We also generated a list of the 10 best match-
ing proteins (RPS4X, PLG, H1FX, HES5, TFEB, USF2,
GRHPR, TP73, ZMAT2, and LARP4) when the database
was queried with the TCTCGCGAGA motif.
Additionally, the hDREF protein, which was shown to
regulate the expression of ribosomal proteins genes,
is another protein with reported in vitro afﬁnity to
this motif.
26 Surprisingly, none of these 32 proteins
were found within the group of 132 proteins taken
through quantitative statistical analysis of our MS
data. This discrepancy again underlines the difﬁculties
inherent in in vitro methods, where slightly different
conditions (salt, detergent, protein, and DNA probe
concentrations) may signiﬁcantly affect the exper-
imental readout and the ultimate data interpretation.
3.3. Cellular proliferation state increases non-speciﬁc
DNA-binding
We discovered that the composition of protein com-
plexes interacting with the DNA probes relates to the
proliferation status of the cells used for NE prep-
aration. Using a FDR threshold equal to 0.05, our
analysis identiﬁed 13 proteins that bind to ds 16
and 30 bp DNA probes with signiﬁcantly higher afﬁ-
nities during proliferation, compared with quiescent
cells (Table 2). All these proteins are components of
DNA repair process according to the GO annotation
analysis (GO: 0006281). The fold change values of
their relative abundances were signiﬁcantly (P ,
0.02; Mann–Whitney test) decreased by a competitor
and by anti-Ku80 antibody depletion of NEs used in
the binding reactions.
To further characterize the changes in the DNA-
binding afﬁnities of non-speciﬁc binders in response
to mitogenic signalling, quiescent cells were treated
with 15% FBS for 0, 1, 6, and 24 h, after which NEs
were prepared and used in EMSA. Again, the amount
Figure 3. Principal component analysis of the relative abundances
of 132 proteins selected for MS-based quantitative analysis.
Experiments are colour-coded as follows: red, 16 nt single-
stranded (ss) DNA probe, starving cells; blue, 16 bp ds DNA
probe; green, 30 nt ss DNA probe; black, 30 bp ds DNA probe.
252 Palindromic Motif Regulates the HNRNPK Promoter [Vol. 17,of the shifted ds probes increased with extension of
time of serum induction of cells used for NE prep-
aration. Results of a representative experiment with
ds 16 bp DNA probes are presented in Fig. 4A. These
results indicate that either expression of the non-
speciﬁcally interacting proteins in proliferating cells
is increased, or that there is an increased interaction
with non-speciﬁc DNA-binding proteins, or both.
To differentiate between these possibilities, we ana-
lysed equal amounts of proteins from NEs by
western blotting, using anti-Ku80, anti-PARP1, and
anti-hnRNP K antibodies. This analysis revealed
equal amounts of Ku80 and hnRNP K in extracts
from both resting and proliferating cells and moder-
ately increased signal of PARP1 after 6 h of serum
stimulation (Fig. 4B).
3.4. Histone modiﬁcation at promoters with the
palindromic motif TCTCGCGAGA
Chromatin is composed of nucleosomes, in which
147 bp of DNA are wrapped 1.7 times around a
core of two copies each of histone proteins H2A,
H2B, H3, and H4. In vivo positioning and covalent
modiﬁcations of nucleosomes play an important role
in transcriptional regulation. Post-translational
covalent modiﬁcations of histone proteins include
methylation, acetylation, phosphorylation, and ubi-
quitination. Such processes recruit and bind chro-
matin remodelling complexes which alter the
conﬁguration of the chromatin, and in turn, control
gene transcription.
27 There is a high degree of com-
plexity in the number of enzymes, histone modiﬁ-
cations, and variant histones involved in chromatin
regulation.
28 The spatial and temporal intricacies of
Table 2. Relative protein abundances in proliferating vs. resting cells, bound to ds DNA probes
16 bp ds DNA probe 30 bp ds DNA probe
Anti-Ku80
depletion
Anti-Ku80
depletion
Competitor Competitor Competitor Competitor
FC FC FC FC FC FC FC FC
P09874 Poly [ADP-ribose] polymerase 1 5.51 1.66 1.10 1.05 8.68 2.30 0.93 1.37
P12956 ATP-dependent DNA helicase 2
subunit 1
3.66 1.35 1.23 1.65 2.60 1.67 1.05 ND
P13010 ATP-dependent DNA helicase 2
subunit 2
3.47 UP 1.06 ND 6.91 0.57 1.58 ND
P18887 DNA repair protein XRCC1 12.24 4.46 1.58 0.66 7.70 5.80 1.41 0.98
P29372 DNA-3-methyladenine glycosylase 3.26 1.05 1.57 0.96 3.19 ND 1.24 ND
P35249 Replication factor C subunit 4 4.78 1.95 ND ND 6.18 3.06 ND ND
P35250 Replication factor C subunit 2 ND 1.68 ND ND 11.88 1.98 ND ND
P35251 Replication factor C subunit 1 4.22 2.58 ND ND 7.37 2.88 ND ND
P49916 DNA ligase 3 3.89 2.45 1.19 0.84 6.58 3.04 0.58 1.2
P78527 DNA-dependent protein kinase
catalytic subunit
3.31 1.21 1.39 1.24 3.66 1.00 1.93 1.00
P78549 Endonuclease III-like protein 1 5.01 ND ND ND 8.35 ND ND ND
Q7Z2E3 Aprataxin 7.48 1.81 ND ND 7.64 2.02 ND ND
Q96T60 Bifunctional polynucleotide
phosphatase/kinase
7.85 3.74 1.35 1.06 9.89 6.65 0.83 ND
The binding reactions with intact or Ku80-immunodepleted NEs from both proliferating and resting HeLa cells were per-
formed with and without competitor. The eluted proteins were subjected to reduction, alkylation, tryptic digestion, and MS
identiﬁcation, followed by quantitative analysis of MS spectra. FC, fold change in protein abundance; ND, not detected; UP,
detected only in proliferating HeLa cells, bold digits refer to statistically signiﬁcant differences (adjusted P   0.05).
Figure 4. Cellular proliferation state increases the afﬁnity of non-
speciﬁc DNA binders. (A) Electrophoretic mobility shift assay of
in vitro binding of 16 bp ds DNA (P1-16), and a corresponding
mutated probe (P1M-16), to HeLa NEs after 0, 1, 6, and 24 h
of serum stimulation. (B) NEs (5 mg) as in (A) were resolved by
SDS–PAGE and electrotransferred to a PVDF membrane.
Blotted proteins were immunostained with antibodies against
Ku80, PARP1, hnRNP K, and Histone H3.
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suggest that chromatin regulation is at least as impor-
tant to the transcriptional state of a gene as the DNA
cis-elements and trans-factors present in its promoter.
Thus, any complete study of the factors regulating
gene expression must include the chromatin state at
that gene’s locus.
The promoters of expressed genes are characterized
by decreased nucleosome occupancy (particularly a
nucleosome-free region around the transcription
start site), acetylation of H3 and H4 histones (H3Ac
and H4Ac), trimethylation of histone H3 lysine 4
(H3K4me3), and the presence of histone destabilizing
chromatin remodelling complexes.
29 The overall
effect of these modiﬁcations is a general decreased
presence and stability of nucleosomes, and as a
result, increased accessibility to transcription factors
and the RNA polymerase II (RNAPII) complex. On
the other hand, silenced genes are characterized by
a different set of histone modiﬁcations and, in
general, by denser chromatin architecture. Histone
H3 lysine 9 and lysine 27 trimethylation levels
(H3K9me3 and H3K27me3) are highest at silent
genes.
29
To characterize the HNRNPK promoter in greater
detail, we compared it to other promoters bearing
the palindromic motif TCTCGCGAGA (HNRNPH—
heterogeneous ribonucleoprotein H and RPS7—
ribosomal protein S7), well-established constitutively
active housekeeping genes (HGs) (TUBB6—Tubulin
beta-6, GAPDH—glyceraldehyde-3-phosphate dehy-
drogenase), an immediate early gene (EGR1—early
growth response 1), a heat shock-induced gene
(HSP70—heat shock 70 kDa protein), and to a silent
gene (HBB—beta globin). We measured histone modi-
ﬁcation and RNAPII complex levels during serum
stimulation in a ChIP assay (Fig. 5).
The RNAPII complex levels measured on HNRNPK,
HNRNPH, and RPS7 were similar to those at the HGs
(10% of input), and remained relatively unchanged
during serum stimulation. As expected, RNAPII levels
at the HBB promoter were smallest, and levels at the
EGR1 promoter after 1 h of serum treatment were
2-fold higher than quiescent cells, followed by a
return to basal levels at 6 and 24 h. We also observed
progressive accumulation of RNAPII at the HSP70 pro-
moter during the serum time course, from 15.8% of
input up to 24.1% in quiescent cells and after 24 h
in serum, respectively (fold change ¼ 1.52; Fig. 5,
Supplementary Table S5).
We subsequently analysed levels of acetylation of
histone H3 lysine 9/18 (H3K9/18Ac), trimethylation
of H3 lysine 4 (H3K4me3), and trimethylation of H3
lysine 27 (H3K27me3) at the various promoters.
Acetylation of lysines eliminates their positive charge
which, when it occurs on certain histone tails, has
been shown to have a negative effect on the higher
order structure of chromatin, essentially making it
more open. H3K9/18Ac is associated with actively
transcribed genes.
27 As expected, H3Ac levels were
Figure 5. Promoter levels of RNA polymerase II and histone modiﬁcations. HeLa resting (0 h) and serum-treated cells (1, 6, and 24 h) were
used in ChIP assays with antibodies against RNAPII, H3, H3Ac(K9/K18), H3K4me3, and H3K27me3. Isolated DNA was used in real-time
PCR with primers to the promoters of HBB, HNRNPK, TUBB6, GAPDH, HNRNPH, RPS7, HSP70, and EGR1. Data are expressed as percent of
input chromatin for RNAPII, or as ratios of modiﬁed histone marks to total H3 ChIP signals. Data represent the mean+ SD of four
independent experiments.
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remained similar during the serum stimulation on
both palindromic and HG promoters. On the other
hand, H3Ac levels measured at the EGR1 and HSP70
promoters were relatively smaller when compared
with RNAPII amounts. The RNAPII/H3Ac ratios for
EGR1 and HSP70 were 67:1 and 47:1, respectively,
whereas the same measurement for the HBB promo-
ter was 69:1. On the other hand, the ratios for both
palindromic and HG promoters ranged from 11:1
for HNRNPH to 23:1 for RPS7 (Fig. 5, Supplementary
Table S5). H3K4me3 is associated with the 50 ends
of actively transcribed genes; H3K4me3 has been
suggested to mark an open chromatin state by
recruiting ATP-dependent chromatin remodelling
complexes.
27 H3K27me3, however, marks silenced
genes,
29 and appears to be dominant over other acti-
vating marks; genes that are marked with both
K3K27me3 and H3K4me3 are typically silent. As
expected, H3K4me3 was detected at the promoters
of all analysed genes, including HBB. Also as expected,
the H3K27me3 levels for all promoters were lower in
comparison to levels at the transcriptionally silent
HBB. In sum, these results indicate that RNAPII levels
and histone modiﬁcation levels at the promoters con-
taining the palindromic motif TCTCGCGAGA are
similar to those of constitutively active HG promoters.
We also wished to determine whether any of the
proteins belonging to the DNA double-strand break
repair complexes, as determined by EMSA and MS
(Table 2), were present at these promoters. Using
ChIP, we measured the abundances of bound Ku80
and PARP1 at these promoters. PARP1 is responsible
for the synthesis and attachment of polymers of
ADP-ribose from nicotinamide adenine dinucleotide
(NADþ) to the glutamic or aspartic acid residues of
target proteins.
30 PARP1 binds to the HSP70 promoter
in vivo,
31 and therefore we used this gene as a ChIP
positive control for PARP1 binding. Although Ku80
did not bind any of the studied promoters (data not
shown), unexpectedly, our ChIP experiment demon-
strated PARP1 binding not only to the HSP70 promo-
ter, but to all promoters tested, with the highest level
of bound PARP1 protein at the HBB promoter (Fig. 6A
and B). Additionally, we tested an intergenic region
and two sites within the rhodopsin (RHO) gene,
where we found similar levels of PARP1 as measured
at the HBB promoter (Fig. 6B), along with the
expected depletion of RNAPII abundance (data not
shown). Overall, the ChIP assays revealed ubiquitous
binding of PARP1 to various promoters, with signiﬁ-
cantly higher abundance at heterochromatin sites
(Fig. 6C).
A large body of evidence has accumulated which
unambiguously supports the involvement of double-
strand break repair complex proteins in transcriptional
regulation.
32–34 Ku80, Ku70, DNA-PK (DNA-
dependent protein kinase), and PARP1 were among
the most abundant proteins bound to DNA probes,
as quantiﬁed by our MS assay (Table 2).
PARP1, a ubiquitous and abundant nuclear protein,
functions as part of the DNA repair pathway, but also
orchestrates transcription through interactions with
transcription factors, nucleosomes, histone-modifying
proteins, and speciﬁc binding to promoters, enhan-
cers, and insulators.
30 PARP1 was found to display
an afﬁnity not only to ds DNA ends, but also to DNA
secondary structures like hairpins.
35,36 In particular,
the PARP1 promoter contains several imperfect
repeats that are capable of forming a hairpin structure
recognized by PARP1 itself, resulting in self-mediated
transcriptional inhibition.
36 Since the TCTCGCGAGA
motif present in the HNRNPK promoter may form a
hairpin structure in vivo, we speculate that such a
spatial scaffold may attract PARP1. This possibility
could explain the loss of signal in EMSA employing
the mutated 16 nt ss probe, as the correct hairpin
structure would be recognized by PARP1 both in vivo
and in vitro. PARP1 was described as a structural com-
ponent of heterochromatin that modulates transcrip-
tion by self-modiﬁcation in an NAD-dependent
manner.
37 Furthermore, it was shown in vitro that
PARP1 is able to promote the compaction of nucleo-
somes into higher order structures when NAD
þ is
not present; on the contrary, saturating amounts of
NAD
þ caused decondensation.
38 Overall, PARP1 acts
as either an activator or a repressor of speciﬁc genes,
depending on the physiological conditions,
30 and we
cannot rule out the possibility of its direct involve-
ment in the regulation of promoters with the
TCTCGCGAGA motif.
3.5. Chromatin accessibility at promoters with the
palindromic motif TCTCGCGAGA
During gene activation, nucleosomes are displaced
and/or repositioned in a process involving histone
modiﬁcation, ATP-dependent nucleosome remodel-
ling complexes, histone chaperones, and the shufﬂing
of histone variants.
28 Thus, characterizing global
nucleosome positions and their chemical and compo-
sitional modiﬁcations is key to unravelling the mech-
anism of transcriptional regulation.
The advent of massively parallel DNA sequencing
technology has allowed the localization of every
nucleosome across the genomes with a high degree
of accuracy.
39 We made use of publicly available
databases to gain additional insight into chromatin
structures surrounding promoters bearing the
TCTCGCGAGA palindromic motif. We explored data-
sets provided by the ENCODE consortium within
the Open Chromatin project, which, among other
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for multiple cell lines.
19 DNase I HS sites contain a
mixture of cis-regulatory elements, and it has been
shown that there is a striking co-occurrence of HS
with regions of well-positioned nucleosomes.
40
First, we examined the DNase I HS proﬁle within the
HNRNPK promoter (Fig. 7A), averaging the HS proﬁle
for four cell lines. This analysis revealed decreased
values in the HS proﬁle occurring at the palindromic
motif, as well as an oscillating pattern of
hypersensitive DNA that may represent a combination
of trans-elements and positioned nucleosome occu-
pancies within this region. Next, we extracted a HeLa
dataset for 50 genes containing the palindromic
motif TCTCGCGAGA, centred the dataset on that
sequence, and superimposed all HS proﬁles averaged
over a 150 bp window (Fig. 7B). This analysis revealed
that TCTCGCGAGA may deﬁne the boundaries of
open chromatin, as it is ﬂanked by two distinct HS
peaks corresponding to positioned nucleosomes. On
Figure 6. Distribution of PARP1 at heterochromatic and euchromatic sites. HeLa quiescent (0 h) and serum-treated cells (1, 6, and 24 h)
were used in ChIP assays with antibodies against PARP1. Isolated DNA was used in real-time PCR with primers to the intergenic site, two
sites within the RHO gene, and the promoter of HBB (A), as well as the promoters of HNRNPK, TUBB6, GAPDH, HNRNPH, RPS7, HSP70,
and EGR1 (B). Data are expressed as percent of input chromatin and represent the mean+ SD of four independent experiments. (C) The
comparison of PARP1 abundance at heterochromatic and euchromatic sites. The data represent an averaged % of input for all
heterochromatin and euchromatin genes tested separately for each time point. The differences between heterochromatin and
euchromatin in PARP1 occupancy were statistically signiﬁcant (*P, 0.005; unpaired t-test) for all time points tested.
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drome itself may demarcate nucleosomal positions
within promoters bearing it, exhibiting features that
prevent nucleosomal occupancy of this motif.
The control of transcription is one of the most
important and highly regulated steps in eukaryotic
gene expression, and thus is instrumental in orches-
trating the metabolic, growth, replicative, and differ-
entiation states of cells. It is not surprising then, that
transcription is carried out by a complex sequence of
events, any combination of which may be regulated.
Studies that investigate gene regulation are greatly
facilitated by methods that characterize the inter-
actions between proteins and DNA. Several methods
have been developed to identify the direct binding
of proteins to DNA sequences. In the classical DNA
footprinting protocol, sequences that bind to a
protein of interest are determined by identifying
regions of DNA that are protected from digestion by
exonuclease III or DNase I. The protected sequence
corresponds to the ‘footprint’ the protein leaves on
the DNA during digestion.
41 Another classical
method, EMSA, involves the retardation of a radio-
labelled DNA probe by the binding of a protein of
interest (or by a protein within a complex), indicating
a molecular interaction.
23 All of these methods
involve the in vitro interaction between a recombi-
nant or NE-extracted protein with a naked segment
of DNA, eliminating the chromatin context and the
possible modiﬁcation state(s) of the protein of inter-
est. Similarly, assays utilizing reporter genes fail to
take into account the local chromatin context,
whereas potential cis-elements (promoters and
enhancers) are tested using transient transfections,
Figure 7. An open chromatin proﬁle at the promoters with the TCTCGCGAGA motif. (A) Averaged proﬁle of DNase-seq tracks surrounding
the HNRNPK promoter (chr9:85785291-85785515) acquired for HepG2, HeLa, k562, and GM12878 cell lines, SD as whiskers. Data
were obtained from the ENCODE Open Chromatin, Duke DNase-seq Base Overlap Signal datasets. The mammal conservation data were
taken from Placental Mammal Basewise Conservation track deposited in the UCSC browser (hg18 genome assembly) http://genome.
ucsc.edu. (B) Averaged HeLa cell proﬁle of DNase-seq tracks surrounding 50 promoters bearing the TCTCGCGAGA motif. The CisRED
(http://www.cisred.org) Human 9 database was queried with TCTCGCGAGA, and the resulting coordinates of 50 promoters were
used to extract the DNase-seq tracks from the ENCODE Open Chromatin, Duke DNase-seq Base Overlap Signal dataset. The open
chromatin proﬁles were superimposed over the TCTCGCGAGA sequence present in each of the 50 promoters and extended over a
150 bp window. The plot represents an averaged value of DNase-seq signal for 50 promoters.
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nucleus.
20 Despite improvements in both compu-
tational prediction of functional DNA sites and exper-
imental veriﬁcation techniques, current methods
allow only snapshots of the transcription process,
and as such favour indirect conclusions.
Recent advancements in high-throughput microar-
ray (ChIP-chip) and sequencing methods (ChIP-Seq)
have increased our understanding of chromatin com-
position, revealing transcription factor binding sites
(TFBS),
42,43 chromatin accessibility,
44 histone modiﬁ-
cations,
45 and nucleosome positions
39 on a genome-
wide scale. These varied experimental datasets
augment computational TFBS prediction methods,
and aid in the description of transcriptional regulation
on the scales of single genes to the entire genome.
3.6. Conclusions
In the present study, we have characterized the mol-
ecular features of the palindromic motif TCTCGCGAGA,
found not only in the HNRNPK promoter but also, as
described in our previous work,
12 a potential cis-regu-
latory element of 5% of human genes. We used a
reporter system assay to show that out of four ident-
iﬁed HNRNPK promoters, the one containing the palin-
dromic motif exhibits the highest expression of a
reporter gene. Although EMSA and MS analyses, per-
formed to discover the palindrome-binding transcrip-
tion factor, did identify a complex of DNA-binding
proteins, neither method unambiguously identiﬁed
the relevant direct trans-acting protein(s). Moreover,
for a collection of proteins functionally implicated in
DNA repair processes we observed that changes in
their afﬁnity to ds DNA probes are related to the pro-
liferation status of the cells.
To analyse the chromatin conﬁguration at the
HNRNPK promoter, we performed comparative ChIP
experiments of RNAPII occupancy and histone modiﬁ-
cation density among the promoters of housekeeping,
inducible, and silent genes. Our analysis revealed that
promoters with the TCTCGCGAGA motif display prop-
erties of the promoters of HGs (GAPDH and TUBB6),
containing similar RNAPII levels and relatively more
H3Ac modiﬁcations than inducible and silent genes.
The analyses of open chromatin data provided by
the ENCODE project revealed that the TCTCGCGAGA
motif has features that promote constitutive openness
of the chromatin and favor DNA accessibility. This
function could be due to the binding of an
unknown transcription factor, a hairpin spatial struc-
ture preventing nucleosome occupancy, or both. In
sum, experimental observations using in vitro
methods and analyses of open chromatin data
support the function of this sequence in local nucleo-
somal organization, resulting in the regulation of
transcription of the HNRNPK gene. Our ﬁndings
suggest that the TCTCGCGAGA motif may play a criti-
cal role in regulating and establishing nucleosome
patterns at the promoters containing it. Further
advancements in analytical methods should elucidate
the comprehensive picture of the function of this
motif in gene expression regulation.
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